RPTX
Companies
NASDAQ
Repare Therapeutics Inc.
Health Care
$1.41
+$0.10 (+7.63%)
Price Chart
Overview
About RPTX
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
Market Cap
$164.7M
Volume
263.3K
Avg. Volume
575.5K
P/E Ratio
-0.46127945
Dividend Yield
0.00%
Employees
176.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.26
High Correlation
Volatility
High (0.99)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, RPTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$164.7M
Volume263.3K
P/E Ratio-0.46
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025